High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$11.9M
$11,862,892
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-26 | $644,513 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-26 | $810,817 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-26 | $318,952 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -11.2%
|
2026-03-26 | $848,699 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-26 | $341,859 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -13.5%
|
2026-03-16 | $711,090 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-16 | $60,166 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-16 | $548,035 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-09 | $319,059 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-04 | $454,967 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -18.0%
|
2026-03-04 | $822,621 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -19.1%
|
2026-03-04 | $723,783 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-01-29 | $155,375 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $50,178 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $11,156 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $40,880 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $138,448 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -11.0%
|
2025-12-16 | $289,449 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $236,640 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $135,617 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $85,840 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -11.3%
|
2025-12-16 | $378,287 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $144,425 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $51,265 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -36.5%
|
2025-12-09 | $579,620 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -38.5%
|
2025-10-29 | $294,107 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-10-29 | $547 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -25.8%
|
2025-09-30 | $72,134 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $22,046 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -17.0%
|
2025-09-30 | $60,458 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -34.6%
|
2025-09-30 | $480,160 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $116,506 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $63,690 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -61.3%
|
2025-09-30 | $560,457 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $15,460 | S | Form 4 |
|
WGS
S
GeneDx Holdings Corp.
Stueland Katherine
• CEO
Sell to CoverΔOwn -41.9%
2025-09-16
$1,275,585Large
|
||||||
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -41.9%
|
2025-09-16 | $1,275,585Large | S | Form 4 |